Partition functions and double-trace deformations in AdS/CFT

We study the effect of a relevant double-trace deformation on the partition function (and conformal anomaly) of a CFT at large N and its dual picture in AdS. Three complementary previous results are brought into full agreement with each other: bulk and boundary computations, as well as their formal identity. We show the exact equality between the dimensionally regularized partition functions or, equivalently, fluctuational determinants involved. A series of results then follows: (i) equality between the renormalized partition functions for all d; (ii) for all even d, correction to the conformal anomaly; (iii) for even d, the mapping entails a mixing of UV and IR effects on the same side (bulk) of the duality, with no precedent in the leading order computations; and finally, (iv) a subtle relation between overall coefficients, volume renormalization and IR-UV connection. All in all, we get a clean test of the AdS/CFT correspondence beyond the classical SUGRA approximation in the bulk and at subleading O(1) order in the large-N expansion on the boundary.Comment: 18 pages, uses JHEP3.cls. Published JHEP versio

Sequence-related off-target effect of Dz13 against human tumor cells and safety in adult and fetal mice following systemic administration

The oligonucleotide Dz13, a DNA enzyme that cleaves c-Jun mRNA, is capable of inhibiting various model tumors in mice. However, to date, a thorough examination of its target specificity in tumor cells has not been performed. In addition, an evaluation of its safety in a mammalian whole organism system has not been carried out. Dz13 mutated oligonucleotides were designed and tested in a proliferation assay. Dz13 was also tested for its safety in vivo when administered intravenously in a bolus dose, or systemically in an in utero assay. While Dz13 down-regulated target gene (c-Jun) expression in human tumor cells, c-Jun siRNA failed to cause cell growth inhibition. Furthermore, alteration of contiguous G motifs in Dz13 flanking arms inhibits cell death activity, but removal of the same from the catalytic core can increase cell death activity. A 20mer (truncated) derivative Dz13 exhibited similar activity. Dz13 was not toxic to blood and solid tissues in adult or fetal mice, though slight hepatotoxicity was noted with histology. It was also void of adverse effects to the physiological processes of angiogenesis and apoptosis. Collectively, the data support the safety of Dz13 and its activity attributed to off-target effects